Kestrel Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-820,500
| Closed | -$2.59M | – | 46 |
|
|
2020
Q3 | $2.59M | Buy |
820,500
+49,000
| +6% | +$154K | 1.49% | 27 |
|
|
2020
Q2 | $2.25M | Sell |
771,500
-99,800
| -11% | -$290K | 1.43% | 28 |
|
|
2020
Q1 | $2.46M | Buy |
+871,300
| New | +$2.46M | 1.9% | 24 |
|
|
2019
Q1 | – | Sell |
-1,383,100
| Closed | -$4.01M | – | 49 |
|
|
2018
Q4 | $4.01M | Sell |
1,383,100
-81,900
| -6% | -$238K | 2.02% | 22 |
|
|
2018
Q3 | $3.85M | Sell |
1,465,000
-120,500
| -8% | -$317K | 1.56% | 32 |
|
|
2018
Q2 | $3.71M | Sell |
1,585,500
-48,500
| -3% | -$113K | 1.36% | 34 |
|
|
2018
Q1 | $4.8M | Sell |
1,634,000
-55,800
| -3% | -$164K | 1.81% | 28 |
|
|
2017
Q4 | $4.63M | Sell |
1,689,800
-45,700
| -3% | -$125K | 1.61% | 30 |
|
|
2017
Q3 | $5.88M | Sell |
1,735,500
-2,700
| -0.2% | -$9.15K | 2.08% | 26 |
|
|
2017
Q2 | $4.29M | Buy |
+1,738,200
| New | +$4.29M | 1.59% | 33 |
|